Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
567,362,612
-
Share change
-
-25,673,939
-
Total reported value
-
$26,075,006,560
-
Put/Call ratio
-
99%
-
Price per share
-
$46.01
-
Number of holders
-
782
-
Value change
-
-$1,241,530,082
-
Number of buys
-
326
-
Number of sells
-
387
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q3 2016
As of 30 Sep 2016 TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) had 782 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 567,362,612 shares of stock of the company.
Largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, BARROW HANLEY MEWHINNEY & STRAUSS LLC, Capital Research Global Investors, Viking Global Investors LP, LAZARD ASSET MANAGEMENT LLC, WADDELL & REED FINANCIAL INC, Bank of New York Mellon Corp, PAULSON & CO. INC., and Invesco Ltd..
This table shows 784 institutional shareholders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.